Comparison of hematologic recovery between autologous peripheral blood stem cell plus bone marrow transplants and simple autologous bone marrow transplant
Zhou Shu
Abstract
Zhou Shu
Abstract
Objective[WT5BZ]:To compare the speeds of engraftment and concerning clinical data between autologous peripheral blood stem cell plus bone marrow transplants (APBSCT+ABMT)and simple autologous bone marrow transplant(ABMT).[WT5HZ]Methods:[WT5BZ]APBSCT+ABMT( n =10) and ABMT( n =10) were used on the treatment of acute leukemia and lymphoma patients,their data were studied.[WT5HZ]Results:[WT5BZ]The average days reach WBC1.0×10 9·L 1 ,N0.5×10 9·L 1 and Plt50×10 9·L 1 were 10,10.5,12.5 in APBSCT+ABMT group and 15,17,24 in ABMT group respectively( P 0.05).There was a significant decrease in the number of plasma and platelets transfusions in the APBSCT+ABMT group as compared with ABMT group( P 0.01).The rate of Tienam use was significantly greater in ABMT group than in APBSCT+ABMT group( P 0.05, P 0.01).There was a significant difference about the rate and degree of bleeding between these two groups ( P 0.05),and also a significant shorting of living in laminar air flow bioclean room in APBSCT+ABMT group than in ABMT group ( P 0.01).No difference was seen between two groups about reducing of hemoglobin and the number of red blood cells transfusion( P 0.05).[WT5HZ]Conclusion:[WT5BZ]APBSCT+ABMT can improve the rate of hematologic recovery,and thus,decrease the rate of infection,bleeding,transfusion,antibiotics usage and length of hospitalization,it is an effective therapy for malignancies.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective[WT5BZ]:To compare the speeds of engraftment and concerning clinical data between autologous peripheral blood stem cell plus bone marrow transplants (APBSCT+ABMT)and simple autologous bone marrow transplant(ABMT).[WT5HZ]Methods:[WT5BZ]APBSCT+ABMT( n =10) and ABMT( n =10) were used on the treatment of acute leukemia and lymphoma patients,their data were studied.[WT5HZ]Results:[WT5BZ]The average days reach WBC1.0×10 9·L 1 ,N0.5×10 9·L 1 and Plt50×10 9·L 1 were 10,10.5,12.5 in APBSCT+ABMT group and 15,17,24 in ABMT group respectively( P 0.05).There was a significant decrease in the number of plasma and platelets transfusions in the APBSCT+ABMT group as compared with ABMT group( P 0.01).The rate of Tienam use was significantly greater in ABMT group than in APBSCT+ABMT group( P 0.05, P 0.01).There was a significant difference about the rate and degree of bleeding between these two groups ( P 0.05),and also a significant shorting of living in laminar air flow bioclean room in APBSCT+ABMT group than in ABMT group ( P 0.01).No difference was seen between two groups about reducing of hemoglobin and the number of red blood cells transfusion( P 0.05).[WT5HZ]Conclusion:[WT5BZ]APBSCT+ABMT can improve the rate of hematologic recovery,and thus,decrease the rate of infection,bleeding,transfusion,antibiotics usage and length of hospitalization,it is an effective therapy for malignancies.
Key concepts: Medicine, Bone marrow, Autologous blood, Blood transfusion, Leukemia, Surgery, Internal medicine